JBGClass II

Glucose-6-Phosphate Dehydrogenase (Erythrocytic), Spot

21 CFR 864.7360 / Hematology

JBG is the FDA product code for Glucose-6-Phosphate Dehydrogenase (Erythrocytic), Spot, a class II device type, regulated under 21 CFR 864.7360. As of 2026-09-10, FDA records hold no 510(k) clearances under this code and no recalls.

Classification record

Product code: JBG
Device name: Glucose-6-Phosphate Dehydrogenase (Erythrocytic), Spot
Regulation: 21 CFR 864.7360
Device class: Class II
Review panel: Hematology
Submission type: 510(k)
Implant: No
Life sustaining or supporting: No
GMP exempt: No
Third party review eligible: Yes
Ingested clearances: 0
Ingested recalls: 0

Companies listing this code with FDA

Companies whose registered establishments list this code

Trinity Biotech, PLC

Recent clearances

Product code JBG

FDA records hold no clearances under product code JBG.

Recent recalls

Product code JBG

FDA records show no recalls under product code JBG.

MDM coverage of this record lists here, newest first.

About this record

Sourced from the FDA device classification database, ingested from openFDA. The definition, regulation number, device class and review panel are FDA’s own fields, reproduced without editing.

MDM adds the counts: clearances by decision year, the applicants holding the most clearances under this code, recalls that name it, and the registered establishments that list it. Every count is computed from ingested records only.

Data as of 2026-10-05, the FDA export date for this dataset. Page last changed 2026-09-05. View this product code on fda.gov (opens on fda.gov)